The France Bioresorbable Polymers Market was valued at $17.5 Million in 2024 and projected to reach to $29.5 Million by 2029, representing a compound annual growth rate of 11.0%. France's bioresorbable polymers market is poised for significant expansion, driven by increasing adoption in orthopedic implants, cardiovascular devices, and drug delivery systems.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
France's bioresorbable polymers market is valued at $17.5 million in 2024, with strong growth trajectory positioning the country as a key European hub for advanced biomaterials.
An 11.0% CAGR through 2029 demonstrates France's accelerating adoption of bioresorbable polymers, outpacing broader European trends in sustainable medical device innovation.
France's robust pharmaceutical and healthcare ecosystem, combined with established medical device manufacturing capabilities, creates ideal conditions for bioresorbable polymer integration and commercialization.
The market is projected to reach $29.5 million by 2029, representing a 68.6% increase from 2024, reflecting growing demand for biocompatible solutions in French medical applications.
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | PLGA (Type) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 11.6% from 2024 to 2029 |
| Largest Segment | ORTHOPEDIC DEVICES (Application) |
| Market Size Base Year (Billions) | ~USD 0.5 (2024) |
| Revenue Forecast (Billions) | ~USD 0.87 (2029) |
| Segments Covered | Type, Application |
2 segment dimensions are covered across the global market.
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|
| DRUG DELIVERY | 5.94 | 6.53 | 7.21 | 8.02 | 8.96 | 10.04 | 11.27 | 11.6 |
| ORTHOPEDIC DEVICES | 8.76 | 9.55 | 10.48 | 11.56 | 12.83 | 14.28 | 15.91 | 10.7 |
| OTHER APPLICATIONS | 1.27 | 1.39 | 1.52 | 1.68 | 1.86 | 2.07 | 2.31 | 10.8 |
| TOTAL | 15.97 | 17.47 | 19.22 | 21.26 | 23.66 | 26.4 | 29.5 | 11 |
France's bioresorbable polymers market was valued at $17.5 million in 2024 and is expected to reach $29.5 million by 2029.
France's bioresorbable polymers market is growing at a compound annual growth rate (CAGR) of 11.0% from 2024 to 2029.
France's demand is driven by surgical implants, drug delivery systems, tissue engineering, orthopedic devices, cardiovascular applications, and dental solutions.
France benefits from advanced healthcare infrastructure, strong regulatory support, significant R&D investment, and its position as a European innovation hub for biomaterials.
Growth is supported by increasing demand for sustainable medical solutions, expanding clinical applications, manufacturing capacity expansion, and healthcare innovation investments in France.
The study involved four major activities in estimating the market size for bioresorbable polymers market. Exhaustive secondary research was done to collect information on the market, the peer market, and the parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, the market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.
Secondary sources used in this study included annual reports, press releases, and investor presentations of companies; white papers; certified publications; articles from recognized authors; and gold standard & silver standard websites such as Factiva, ICIS, Bloomberg, and others. The findings of this study were verified through primary research by conducting extensive interviews with key officials such as CEOs, VPs, directors, and other executives. The breakdown of profiles of the primary interviewees is illustrated in the figure below:
The bioresorbable polymers market comprises several stakeholders, such as raw material suppliers, end-product manufacturers, and regulatory organizations in the supply chain. The demand side of this market is characterized from key opinion leaders in various applications for the bioresorbable polymers market. The supply side is characterized by advancements in technology and diverse application industries. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information.
The following is a breakdown of the primary respondents:
Note: Tier 1, Tier 2, and Tier 3 companies are classified based on their market revenue in 2022/ 2023, available in the public domain, product portfolios, and geographical presence.
Other designations include consultants and sales, marketing, and procurement managers.
To know about the assumptions considered for the study, download the pdf brochure
| COMPANY NAME | DESIGNATION | |
|---|---|---|
| Evonik Industries AG | Sales Manager | |
| Ashland Global Holdings Inc. | R&D Manager | |
| KLS Martin Group | Global R&D Head | |
| DSM Biomedical | Business Development Manager | |
| Poly-Med Incorporated | Regional Sales Manager | |
Both top-down and bottom-up approaches were used to estimate and validate the total size of the bioresorbable polymers market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

After arriving at the overall market size—using the market size estimation processes as explained above—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the bioresorbable polymers industry.
The bioresorbable polymers are the type of polymers. They are designed to naturally degrade and be absorbed within biological environments. These polymers are utilized in medical and healthcare sectors, where they are used to manufacture orthopedic devices and drug delivery systems. The demand of bioresorbable polymers influenced by the innovation in medical devices and the need for the eco-friendly alternatives to the permanent implants. The key components of the bioresorbable polymers are PLA, PGA, PLGA, and PCL.
Full forecast, segment splits, and company analysis for all Bioresorbable Polymers Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report